L26/P-047 High sperm retrieval but impaired embryological outcomes in couples with AZFc microdeletion undergoing testicular sperm extraction (TESE) – intracytoplasmic sperm injection (ICSI)
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von H. Arakawa und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What are the embryological and clinical outcomes of TESE–ICSI in couples with AZFc microdeletion compared with unexplained non-obstructive azoospermia? Summary answer AZFc microdeletion is associated with favourable sperm retrieval but impaired embryological outcomes and a reduced pregnancy rate, although successful live births remain achievable after TESE–ICSI. What is known already Male infertility is frequently attributable to genetic abnormalities, among which microdeletions of the azoospermia factor (AZF) region on the Y chromosome represent one of the most common genetic causes of impaired spermatogenesis. The AZF region comprises three functional subregions—AZFa, AZFb, and AZFc—each associated with distinct patterns and severities of spermatogenic failure. AZFc microdeletion, the most commonly identified subtype, is characterised by marked phenotypic heterogeneity ranging from oligozoospermia to non-obstructive azoospermia (NOA). Although advances in sperm retrieval techniques and ICSI have expanded reproductive opportunities for affected men, large comparative data on embryological and clinical outcomes in AZFc microdeletion remain limited. Study design, size, duration This retrospective study was conducted at a single centre between September 2013 and October 2025. Among 2003 men with NOA who underwent genetic screening, cases undergoing microdissection testicular sperm extraction (micro TESE) were included. A total of 1,184 men were analysed, comprising 82 men with AZFc microdeletion and 1,102 men with unexplained non-obstructive azoospermia (uNOA) without AZF deletions. Participants/materials, setting, methods Micro TESE was performed in all NOA cases, and when sperm were retrieved, ICSI was undertaken. Surgical sperm retrieval outcomes, fertilisation parameters, embryo development, and clinical outcomes were assessed. Embryo development was evaluated by the proportion of good-quality blastocyst, defined as those graded ≥3BB on day5 according to the Gardner classification. Categorical variables were compared using the chi-square test, and continuous variables were compared using Student’s t-test or non-parametric tests, as appropriate. Main results and the role of chance This study evaluated treatment outcomes in men with azoospermia harbouring AZFc microdeletions in comparison with those diagnosed with unexplained NOA. Among 1969 azoospermic men who underwent genetic testing, 223 Y-chromosome microdeletions were identified (11.3%), including 82 men with AZFc microdeletion. Testicular sperm retrieval by micro TESE was achieved at a significantly higher frequency in the AZFc microdeletion group than in the uNOA group (80.8% vs. 19.7%, p < 0.001). Despite favourable sperm retrieval outcomes, embryological performance following ICSI was significantly impaired in the AZFc microdeletion group, with lower rates of normal fertilisation (2PN: 30.6% vs. 51.5%, p < 0.001), blastocyst development (19.1% vs. 46.7%, p < 0.01), and good-quality blastocyst formation (8.2% vs. 22.3%, p < 0.001) compared with the uNOA group. Clinical pregnancy rates per embryo transfer did not differ significantly between the two groups (30.4% vs. 33.8%). Similarly, ongoing pregnancy rates were comparable (21.7% vs. 26.8%). However, the clinical pregnancy rate per patient was significantly lower in the AZFc microdeletion group than in the uNOA group (55.1% vs. 72.5%, p < 0.01).To date, 39 healthy children have been born to couples with AZFc microdeletion, indicating that despite impaired embryological performance, successful live births remain achievable in this genetically defined subgroup. Limitations, reasons for caution This study is limited by its retrospective single-centre design and the relatively small number of patients with AZFc microdeletion. Potential confounding factors, including female partner characteristics and clinical heterogeneity, could not be fully controlled. Long-term follow-up data on offspring remain limited, and further prospective studies with extended follow-up are warranted. Wider implications of the findings These findings provide important information for counselling couples with AZFc microdeletion. Although sperm retrieval is successful, impaired embryological outcomes and a reduced pregnancy rate per patient should be considered. Nevertheless, the achievement of multiple healthy live births confirms that TESE–ICSI remains a valuable reproductive option for this genetically defined subgroup. Trial registration number No
Zitieren
APA
Arakawa, H., Kobayashi, K., Mizuta, S., Yamaguchi, K., Doi, K., Matsubayashi, H., Takeuchi, T., & Ishikawa, T. (2026). L26/P-047 High sperm retrieval but impaired embryological outcomes in couples with AZFc microdeletion undergoing testicular sperm extraction (TESE) – intracytoplasmic sperm injection (ICSI). Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.383
Vancouver
Arakawa H, Kobayashi K, Mizuta S, Yamaguchi K, Doi K, Matsubayashi H, et al. L26/P-047 High sperm retrieval but impaired embryological outcomes in couples with AZFc microdeletion undergoing testicular sperm extraction (TESE) – intracytoplasmic sperm injection (ICSI). Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.383
BibTeX
@article{Arakawa2026,
author = {Arakawa, H. and Kobayashi, K. and Mizuta, S. and Yamaguchi, K. and Doi, K. and Matsubayashi, H. and Takeuchi, T. and Ishikawa, T.},
title = {L26/P-047 High sperm retrieval but impaired embryological outcomes in couples with AZFc microdeletion undergoing testicular sperm extraction (TESE) – intracytoplasmic sperm injection (ICSI)},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.383}
}
EUVIMED